Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

The Safety and Tolerability of CLZ-2002 in Patients With Charcot-Marie Tooth Disease.

Cellatoz Therapeutics, Inc · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
cell-therapytype-1
charcot marie tooth disease, type 1, charcot-marie-tooth disease, cmt1, cell therapy, tonsillar mesenchymal stem cells (t-msc), neuronal regeneration promoting cells, schwann cell-like cells, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 993485
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.